Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A0A3Q8IMQ4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 164 | 168 | PF00656 | 0.517 |
CLV_C14_Caspase3-7 | 6 | 10 | PF00656 | 0.467 |
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.641 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.471 |
CLV_PCSK_FUR_1 | 196 | 200 | PF00082 | 0.505 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.664 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.471 |
CLV_PCSK_PC7_1 | 3 | 9 | PF00082 | 0.479 |
DOC_PP2B_LxvP_1 | 113 | 116 | PF13499 | 0.509 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.466 |
DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.536 |
DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.600 |
LIG_14-3-3_CanoR_1 | 153 | 162 | PF00244 | 0.717 |
LIG_14-3-3_CanoR_1 | 18 | 23 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 25 | 30 | PF00244 | 0.539 |
LIG_14-3-3_CanoR_1 | 38 | 47 | PF00244 | 0.446 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.649 |
LIG_EH1_1 | 16 | 24 | PF00400 | 0.458 |
LIG_eIF4E_1 | 17 | 23 | PF01652 | 0.476 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.405 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.514 |
LIG_LIR_Gen_1 | 45 | 55 | PF02991 | 0.465 |
LIG_PTAP_UEV_1 | 143 | 148 | PF05743 | 0.531 |
LIG_SH3_3 | 141 | 147 | PF00018 | 0.578 |
LIG_SUMO_SIM_anti_2 | 169 | 179 | PF11976 | 0.687 |
LIG_SUMO_SIM_anti_2 | 75 | 82 | PF11976 | 0.494 |
LIG_SUMO_SIM_par_1 | 105 | 111 | PF11976 | 0.418 |
LIG_SUMO_SIM_par_1 | 134 | 140 | PF11976 | 0.399 |
LIG_TRAF2_1 | 119 | 122 | PF00917 | 0.445 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.600 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.633 |
MOD_CK1_1 | 68 | 74 | PF00069 | 0.634 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.727 |
MOD_GlcNHglycan | 103 | 107 | PF01048 | 0.557 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.529 |
MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.624 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.484 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.710 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.663 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.606 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.619 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.698 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.676 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.638 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.466 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.677 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.573 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.664 |
MOD_Plk_2-3 | 186 | 192 | PF00069 | 0.671 |
MOD_Plk_2-3 | 75 | 81 | PF00069 | 0.606 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.457 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.663 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.452 |
MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.605 |
TRG_DiLeu_BaEn_1 | 75 | 80 | PF01217 | 0.502 |
TRG_ER_diArg_1 | 196 | 199 | PF00400 | 0.662 |
TRG_Pf-PMV_PEXEL_1 | 198 | 202 | PF00026 | 0.667 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBI1 | Leptomonas seymouri | 46% | 92% |
A0A1X0P5H7 | Trypanosomatidae | 33% | 100% |
A0A422NR35 | Trypanosoma rangeli | 38% | 100% |
A4HN35 | Leishmania braziliensis | 72% | 99% |
A4IBQ3 | Leishmania infantum | 99% | 100% |
C9ZYX2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 81% |
E9AFI8 | Leishmania major | 88% | 99% |
E9B6P3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 99% |
V5BD49 | Trypanosoma cruzi | 34% | 100% |